DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Retrovir (Zidovudine) - Adverse Event Reports - Life Threatening Events - Drug Exposure During Pregnancy

 



Index of reports > Cases resulting in life threatening events (13) > Cases with Drug Exposure During Pregnancy (4)

Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes cases resulting in life threatening events where reactions include drug exposure during pregnancy.

Adverse event in male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-06-29

Patient: male, weighing 2.8 kg (6.2 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Combivir
    Indication: Antiviral Prophylaxis
    Start date: 2005-02-17
    End date: 2005-04-06

Retrovir
    Dosage: 1.1ml twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2005-04-06
    End date: 2005-05-17

Other drugs received by patient: Retrovir; Kaletra



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-03-30

Patient: female, weighing 1.0 kg (2.2 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Necrotising Enterocolitis Neonatal

Adverse event resulted in: life threatening event

Suspect drug(s):
Retrovir
    Dosage: 1.6mg twice per day
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-19
    End date: 2007-01-26

Retrovir
    Dosage: 2mg twice per day
    Administration route: Oral
    Start date: 2007-01-26
    End date: 2007-02-08

Other drugs received by patient: Antiretroviral Medications



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-02-12

Patient: male

Adverse reactions / side effects: Diarrhoea Neonatal, Hyperlactacidaemia, Anion GAP Increased, Coagulopathy, Dyskinesia, Blood Albumin Decreased, Prothrombin Time Prolonged, Neonatal Disorder, Activated Partial Thromboplastin Time Prolonged, Caesarean Section, Hepatic Encephalopathy, Vertical Infection Transmission, Gamma-Glutamyltransferase Increased, Developmental Delay, HIV Infection, Fever Neonatal, Abdominal Distension, Alanine Aminotransferase Increased, Vomiting Neonatal, Convulsion, Drug Exposure During Pregnancy, Dehydration, Aspartate Aminotransferase Increased, Maternal Condition Affecting Foetus, Ammonia Increased, Feeding Disorder

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Epivir
    Dosage: transplacentary
    Indication: HIV Infection

Nevirapine
    Dosage: transplacentary
    Indication: HIV Infection

Retrovir
    Dosage: oral
    Administration route: Oral

Retrovir
    Dosage: transplacentary
    Indication: HIV Infection

Stavudine
    Dosage: transplacentary
    Indication: HIV Infection



Adverse event in 1 year old male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-01-19

Patient: 1 year old male

Adverse reactions / side effects: Malaise, Drug Exposure During Pregnancy, Pregnancy

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Bactrim

Combivir

Kaletra

Retrovir

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009